(Q35163585)

6 August 2017

1 reference

title

Hydroxyethylrutosides. A review of its pharmacology, and therapeutic efficacy in venous insufficiency and related disorders (English)

1 reference

6 August 2017

1 reference

1 reference

A. N. Wadworth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1282862

9 September 2022

D. Faulds

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1282862

9 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1282862

9 September 2022

publication date

1 December 1992

1 reference

6 August 2017

1 reference

6 August 2017

44

1 reference

6 August 2017

6

1 reference

6 August 2017

1013-1032

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199244060-00009

6 August 2017

0 references

cites work

A double-blind, cross-over trial of O-(beta-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs

1 reference

12 December 2020

Troxerutin in the treatment of haemorrhoids

1 reference

12 December 2020

Diabetic retinopathy: Study of the action of 0-betahydroxyethyl-rutosides (HR) by retinal fluoresceinography

1 reference

12 December 2020

Hazards of compression treatment of the leg: an estimate from Scottish surgeons

1 reference

12 December 2020

Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function

1 reference

12 December 2020

[A 3-month, randomized double-blind dose-response study with 0-(beta-hydroxyethyl)-rutoside oral solutions]

1 reference

12 December 2020

Time course of the anti-oedematous effect of O-(beta-hydroxyethyl)-rutosides in healthy volunteers

1 reference

12 December 2020

Uptake and localisation of O-(beta-hydroxyethyl)-rutosides in the venous wall, measured by laser scanning microscopy

1 reference

12 December 2020

Effect of O-(beta-hydroxyethyl)-rutoside on red cell and platelet functions in man

1 reference

12 December 2020

[Clinical, placebo-controlled double-blind study of venoruton in the treatment of chronic venous insufficiency. Importance of the selection of patients]

1 reference

12 December 2020

Oxerutins in the prevention of recurrence in chronic venous ulceration: randomized controlled trial

1 reference

12 December 2020

The effect of O-(beta-hydroxyethyl)-rutosides (HR) on the skin capillary resistance of rats.

1 reference

12 December 2020

A clinical trial of trihydroxyethylrutoside ("varemoid") in the treatment of haemorrhoids.

1 reference

12 December 2020

Occurrence and treatment of leg-and venous pains in pregnancy

1 reference

12 December 2020

Inhibitory effect of the flavonoid O-(beta-hydroxyethyl)-rutoside on increased microvascular permeability induced by various agents in rat skin

1 reference

12 December 2020

[Long-term therapy of retinal vasculopathies with oral administration of high doses of O-(beta-hydroxyethyl)-rutoside]

1 reference

12 December 2020

Biological activity of a semisynthetic flavonoid, O-( -hydroxyethyl)rutoside: light-scattering and metabolic studies of human red cells and platelets

1 reference

12 December 2020

The metabolism and excretion of 7-mono-0-(β-hydroxyethyl) rutoside in the dog

1 reference

12 December 2020

Granulocyte adhesion to endothelium in culture

1 reference

12 December 2020

Study of the activity of a flavonoid, 3-(beta-hydroxyethyl)-rutoside, at high dose levels on venous tone measured by "strain gauge" plethylsmography

1 reference

12 December 2020

The effect of paroven (HR) on the clearance of sodium-24 from the subcutaneous tissues of the foot in patients with varicose veins

1 reference

12 December 2020

Effect of Hydroxyethylrutosides on Blood Oxygen Levels and Venous Insufficiency Symptoms in Varicose Veins

1 reference

12 December 2020

The effect of 0-(β-hydroxyethyl)-rutosides (HR) on the peripheral circulation in patients with chronic venous insufficiency

1 reference

12 December 2020

Acute effects of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose comparison study)

1 reference

12 December 2020

Causes of venous ulceration: a new hypothesis.

1 reference

12 December 2020

The effect of hydroxyethylrutosides on capillary filtration rate in the lower limb of man

1 reference

12 December 2020

[Dose-response study with O-(beta-hydroxyethyl)-rutoside oral solution]

1 reference

12 December 2020

Evaluation of the microcirculatory effects of Venoruton in patients with chronic venous hypertension by laserdoppler flowmetry, transcutaneous PO2 and PCO2 measurements, leg volumetry and ambulatory venous pressure measurements

1 reference

12 December 2020

The effect of 0-(β-hydroxyl)-rutosides (HR) on peripheral blood vessels of the lower extremities in idiopathic oedema

1 reference

12 December 2020

The effects of O-(beta-hydroxy-ethyl)-rutosides (HR) on acute lymphoedema in rats' thighs, with and without macrophages

1 reference

12 December 2020

[DIABETIC RETINOPATHY: POSSIBILITIES AND LIMITATION OF ITS TREATMENT WITH INCREASED DOSES OF TRIHYDROXYETHYLRUTOSIDE, A FACTOR P.]

1 reference

12 December 2020

Effect of o-(beta-hydroxyethyl)-rutosides on the microrheology of human blood under defined flow conditions

1 reference

12 December 2020

Paroven in the treatment of chronic venous insufficiency

1 reference

12 December 2020

Troxerutin in Raynaud's syndrome.

1 reference

12 December 2020

Vascular obturation in diabetic retinopathy using 0-beta-hydroxyethyl-rutoside

1 reference

12 December 2020

Effects of beta-hydroxyethyl rutosides (H-R) administered post burn after thermal-injury-induced plasma volume loss in the nonresuscitated dog

1 reference

12 December 2020

Effect of a flavonoid on the capillary resistance of the rectal mucosa in hepatic cirrhosis

1 reference

12 December 2020

Effects of hydroxyethyl rutosides upon the permeability of single capillaries in the frog mesentery

1 reference

12 December 2020

Effects of O-(beta-hydroxyethyl)-rutosides (HR) and indomethacin on transcapillary macromolecular transport and prostaglandins following scalding injury

1 reference

12 December 2020

Effect of inhibition of PGE2-activity on FITC-dextran permeability in the hamster microvasculature

1 reference

12 December 2020

Quantitative determination of O-(beta-hydroxyethyl)-rutosides in serum by high-performance liquid chromatography

1 reference

12 December 2020

[TEffect of trihydroxyethylrutoside in diabetic retinopathy]

1 reference

12 December 2020

A double blind trial of oral O. B-hydroxyethyl rutosides for stasis leg ulcers

1 reference

12 December 2020

A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome

1 reference

12 December 2020

[Dosage of O-beta hydroxyethylrutoside in chronic venous insufficiency]

1 reference

12 December 2020

Lymphatic microangiopathy: a complication of severe chronic venous incompetence (CVI).

1 reference

12 December 2020

Metabolism of the hydroxyethylrutosides. II. Excretion and metabolism of 3',4',7-tri-O-(beta-hydroxyethyl) rutoside and related compounds in laboratory animals after parenteral administration

1 reference

12 December 2020

Suppression of the desquamating effect of smoking on the human endothelium by hydroxyethylrutosides

1 reference

12 December 2020

The effect of hydroxyethylrutosides after acute and chronic oral administration in patients with venous diseases. A double-blind study.

1 reference

12 December 2020

[Treatment of acute symptoms of hemorrhoid disease with high-dose oral O-(beta-hydroxyethyl)-rutosides]

1 reference

12 December 2020

White cell accumulation in dependent legs of patients with venous hypertension: a possible mechanism for trophic changes in the skin.

1 reference

12 December 2020

Metabolism and pharmacokinetics of hydroxyethylated rutosides in animals and man

1 reference

12 December 2020

The fate of orally and parenterally administered flavonoids in the mammal. The significance of biliary excretion

1 reference

12 December 2020

General practice treatment of symptoms of venous insufficiency with oxerutins. Results of a 660 patient multicentre study in the UK

1 reference

12 December 2020

A clinical trial of hydroxyethylrutosides in the treatment of haemorrhoids of pregnancy

1 reference

12 December 2020

[Renal excretion of trihydroxy-ethylrutoside (Venoruton) after parenteral and oral administration]

1 reference

12 December 2020

Therapy of stasis symptoms following breast amputation and irradiation. Experiences with physical therapy and Venoruton

1 reference

12 December 2020

Warfarin and hydroxyethylrutosides in deep vein thrombosis.

1 reference

12 December 2020

Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration.

1 reference

12 December 2020

[HPLC determination of troxerutin in plasma and urine following oral administration in man]

1 reference

12 December 2020

An oral treatment for haemorrhoids

1 reference

12 December 2020

Macrophage and tissue changes in the developmental phases of secondary lymphoedema and during conservative therapy with benzopyrone

1 reference

12 December 2020

Effect of o-(beta-hydroxyethyl)-rutoside in lymphangiography

1 reference

12 December 2020

Hydroxyethylrutosides during extracorporeal circulation: effect on erythrocyte deformability

1 reference

12 December 2020

Metabolism of hydroxyethylrutosides (HR): metabolism of [14C]-HR in man

1 reference

12 December 2020

Evaluation of capillary permeability and microcirculation in patients with chronic venous hypertension treated with venoruton by the vacuum suction chamber (VSC) device and laser-Doppler flowmetry.

1 reference

12 December 2020

Endothelial injury by nicotine and its prevention

1 reference

12 December 2020

Treatment of Experimental Lymphoedema with the Semi-Synthetic Bioflavonoid O-(β-Hydroxyethyl)-Rutosides (HR)

1 reference

12 December 2020

Effects of O-( -hydroxyethyl)-rutosides (HR) on the increased microvascular permeability in experimental skin burns. Preliminary report

1 reference

12 December 2020

Chronic Venous Insufficiency Treated with Hydroxyethylrutosides (HR)

1 reference

12 December 2020

Clinical Study on the Efficacy of O-(β-Hydroxyethyl) Rutoside (HR) in Varicosis of Pregnancy

1 reference

12 December 2020

The cause of venous ulceration

1 reference

12 December 2020

TREATMENT OF SKIN- AND MUCOUS MEMBRANE-REACTIONS TO THERAPEUTIC PARTIAL BODY IRRADIATION IN MEGAVOLT THERAPY. (CLINICAL REPORT ON THE STUDIES WITH TRIHYDROXYETHYLRUTOSIDUM)

1 reference

12 December 2020

Effect of Hydroxyethyl Rutosides and Related Compounds on Lipid Peroxidation and Free Radical Scavenging Activity. Some Structural Aspects

1 reference

12 December 2020

A double-blind trial of O-(beta-hydroxyethyl)-rutoside in patients with chronic venous insufficiency

1 reference

12 December 2020

10.2165/00003495-199244060-00009

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

0 references

1 reference